We are live on ! Find out more
DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

1 hedge funds and large institutions have $76K invested in Dicerna Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $73K | Put options by funds: $20K

99% less funds holding

Funds holding: 173 → 1 (-172)

100% less capital invested

Capital invested by funds: $1.25B → $76K (-$1.25B)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 170

Holders
1
Holders Change
-172
Holders Change %
-99.42%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
170
Calls
$73K
Puts
$20K
Net Calls
+$53K
Net Calls Change
-$10.6M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$153M
2
BlackRock
BlackRock
New York
-$116M
3
State Street
State Street
Massachusetts
-$78.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$74.7M
5
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$62.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
MGIM
126
M&G Investment Management
United Kingdom
– -$242 -12,105 Closed
JF
127
Jump Financial
Illinois
– -$238K -11,776 Closed
DCM
128
Dupont Capital Management
Delaware
– -$232K -11,529 Closed
DTL
129
Dynamic Technology Lab
Singapore
– -$231K -11,450 Closed
Mitsubishi UFJ Asset Management
130
Mitsubishi UFJ Asset Management
Japan
– -$226K -11,235 Closed
Teacher Retirement System of Texas
131
Teacher Retirement System of Texas
Texas
– -$219K -10,871 Closed
SAM
132
Shell Asset Management
Netherlands
– -$210K -10,432 Closed
TRCT
133
Tower Research Capital (TRC)
New York
– -$158K -7,813 Closed
Zurich Cantonal Bank
134
Zurich Cantonal Bank
Switzerland
– -$150K -7,465 Closed
Skandinaviska Enskilda Banken (SEB)
135
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$127K -6,300 Closed
VEA
136
Virtus ETF Advisers
New York
– -$113K -5,581 Closed
AIP
137
Ameritas Investment Partners
Nebraska
– -$108K -5,365 Closed
MAM
138
Meeder Asset Management
Ohio
– -$92K -4,619 Closed
OSAM
139
O'Shaughnessy Asset Management
Connecticut
– -$79K -3,887 Closed
Canada Life
140
Canada Life
Manitoba, Canada
– -$79K -3,882 Closed
US Bancorp
141
US Bancorp
Minnesota
– -$71K -3,559 Closed
Nisa Investment Advisors
142
Nisa Investment Advisors
Missouri
– -$69 -3,425 Closed
Osaic Holdings
143
Osaic Holdings
Arizona
– -$68K -3,392 Closed
PHK
144
Point72 Hong Kong
Hong Kong
– -$62K -3,077 Closed
CAC
145
Cowen and Company
New York
– -$51K -2,514 Closed
DFCM
146
Dark Forest Capital Management
Puerto Rico
– -$37K -1,843 Closed
PCM
147
Penserra Capital Management
California
– -$35K -1,780 Closed
SOW
148
State of Wyoming
Wyoming
– -$36K -1,774 Closed
Simplex Trading
149
Simplex Trading
Illinois
– -$50K -1,759 Closed
Macquarie Group
150
Macquarie Group
Australia
– -$32K -1,585 Closed
3 4 5
6
7

DRNA Hedge Fund Activity: Q4 2021 in Review

1 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Dicerna Pharmaceuticals, Inc. (DRNA) for Q4 2021, worth a combined $76K — down 100% from $1.25B a quarter earlier.

Sellers outnumbered buyers: 170 funds closed out of DRNA and 0 opened new positions — a net loss of 170 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $153M sold.

  • 1 institutional investor held Dicerna Pharmaceuticals, Inc. (DRNA) as of Q4 2021, down from 173 in Q3 2021.
  • Funds reported $76K of Dicerna Pharmaceuticals, Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Dicerna Pharmaceuticals, Inc. positions in Q4 2021 and 170 closed out, a net change of -170 holders.
  • The largest Dicerna Pharmaceuticals, Inc. seller in Q4 2021 was RTW Investments, an estimated $153M sold.

Based on aggregated 13F filings for Q4 2021.